Brief: Us FDA Approves First OTC Acetaminophen/Naproxen Combination For 12-Hour Pain Relief
BRIEF-Us FDA Approves First OTC Acetaminophen/Naproxen Combination For 12-Hour Pain Relief July 24 (Reuters) - US FDA:
US FDA - APPROVES TYLENOL WITH NAPROXEN, FIRST OTC ACETAMINOPHEN/NAPROXEN COMBINATION FOR 12-HOUR PAIN RELIEF
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kenvue
See all newsBrief: Kenvue To Announce Third Quarter 2026 Results On October 30, 2026
Brief: Kimberly-Clark Corporation Announces Pricing Of $4.9 Billion Private Offering Of Senior Notes
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived (updated)
Media: Kimberly-Clark offers bonds to help fund Kenvue takeover - Bloomberg News
US stocks weekly: AI unwind